Michelle I Lin

4PUBLICATIONS

27CO-AUTHORS

HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 12, 2026

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

|Feb 04, 2026

A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.

Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi

|Jan 27, 2026

Clonal dynamics, tolerance, and adverse events after CD45-ADC-conditioned autologous HSPC transplantation in macaques.

Taha Bartu Hayal, Diana M Abraham, Selami Demirci

|Oct 23, 2025

Remission of <i>TP53</i>-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).

Guenther Koehne, Muhammad U Mushtaq, Lori S Muffly

Pageof 1

Frequent Collaborators

Nirali N Shah

Guenther Koehne

Jennifer S Whangbo

Lori S Muffly

Joseph Maakaron

Sagar S Patel

Joseph C Rimando

Melissa M Lee-Sundlov

2 joint publications

Roni Tamari

2 joint publications

Giacomo Canesin

Frequent Collaborators

Nirali N Shah

Guenther Koehne

Jennifer S Whangbo

Lori S Muffly